M&A · Healthcare · Biological Products, (No Diagnostic Substances)
Celadon Partners SPV 35 Limited to acquire Senti Biosciences Holdings, Inc.
Announced Jul 15, 2026 · Closed Jul 15, 2026
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Celadon Partners SPV 35 Limited
- Target
- Senti Biosciences Holdings, Inc. (SNTI)
- Buyer type
- Private equity
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Jul 15, 2026
Deal protections
- Break fee (target pays)
- $2.5M
- Reverse fee (buyer pays)
- —
- Go-shop
- No-shop
- Financing
- No financing condition
Advisors
- To the acquirer
- Not disclosed
- To the target
- Lincoln International
Sector context · Healthcare
- Comparable deals
- 99 in the prior 24 months
- Premium
- Sector median 49.0%
- EV / Adj. EBITDA
- Sector median 10.9x
- Break fee
- Sector median 3.5%
Timeline
- AnnouncedJul 15, 2026
- ClosedJul 15, 2026